# The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)

> **NCT05926102** · NA · RECRUITING · sponsor: **VA Office of Research and Development** · enrollment: 5000 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **GENETIC:** Precision screening intervention
- **OTHER:** Usual care

## Key facts

- **NCT ID:** NCT05926102
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2029-09-30
- **Final completion:** 2030-09-30
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05926102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05926102, "The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05926102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*